Complaint for Declaratory Judgement
Civil Action No. 1:13-cv-01358-UA; no judge yet assigned.
Filed on Feb. 28, 2013 in the U.S. District Court for the Southern District of New York;

Patents in case

• 8,383,120: “Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate” by Feldmann et. al. Prosecuted by White; John P. Cooper & Dunham LLP. Includes 19 claims (1 indep.). Was application 13/350,065. Granted 2/26/2013.
• 6,270,766: “Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease” by Feldman et. al. and assigned to The Kennedy Institute of Rheumatology. Prosecuted by Hamilton, Brook, Smith & Reynolds, P.C.. Includes 30 claims (5 indep.). Was application 08/690,775. Filed 8/1/1996 & Granted 8/7/2001.
• 7,846,442: “Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate” by Feldmann et. al. and assigned to The Mathilda and Terence Kennedy Institute of Rheumatology Trust. Prosecuted by White; John P. Cooper & Dunham LLP. Includes 22 claims (5 indep.). Was application 11/225,631. Filed 9/12/2005 & Granted 12/7/2010.
• 8,298,537: “Concomitant treatment of rheumatoid arthritis with anti-TNF-.alpha. antibodies and methotrexate” by Feldmann et. al. Prosecuted by White; John P. Cooper & Dunham LLP. Includes 30 claims (4 indep.). Was application 13/350,262. Granted 10/30/2012.